1-4 of 4
Ryo Kurita
Close
Sort by
Journal Articles

Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency

Clinical Trials & Observations
Marja W. Wessels, Marjon H. Cnossen, Thamar B. van Dijk, Nynke Gillemans, K. L. Juliëtte Schmidt, Kirsten van Lom, Divya S. Vinjamur, Steven Coyne, Ryo Kurita, Yukio Nakamura, Stella A. de Man, Rolph Pfundt, Zakia Azmani, Rutger W. W. Brouwer, Daniel E. Bauer, Mirjam C. G. N. van den Hout, Wilfred F. J. van IJcken, Sjaak Philipsen
Journal: Blood Advances
Blood Adv (2021) 5 (9): 2339–2349.
https://doi.org/10.1182/bloodadvances.2020003753
Published: 2021
Includes: Supplemental data
Journal Articles

High level of fetal-globin reactivation by designed transcriptional activator-like effector

Jun Zhan, Maria Johnson Irudayam, Yukio Nakamura, Ryo Kurita, Arthur W. Nienhuis
Journal: Blood Advances
Blood Adv (2020) 4 (4): 687–695.
https://doi.org/10.1182/bloodadvances.2019000482
Published: 2020
Includes: Supplemental data
Journal Articles

A specialized pathway for erythroid iron delivery through lysosomal trafficking of transferrin receptor 2

Shadi Khalil, Maja Holy, Stephen Grado, Robert Fleming, Ryo Kurita, Yukio Nakamura, Adam Goldfarb
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1181–1194.
https://doi.org/10.1182/bloodadvances.2016003772
Published: 2017
Includes: Supplemental data
Journal Articles

KLF1 directly activates expression of the novel fetal globin repressor ZBTB7A/LRF in erythroid cells

Laura J. Norton, Alister P. W. Funnell, Jon Burdach, Beeke Wienert, Ryo Kurita, Yukio Nakamura, Sjaak Philipsen, Richard C. M. Pearson, Kate G. R. Quinlan, Merlin Crossley
Journal: Blood Advances
Blood Adv (2017) 1 (11): 685–692.
https://doi.org/10.1182/bloodadvances.2016002303
Published: 2017
Includes: Supplemental data